Prescription Drug Monitoring Programs (PDMPs) (PDF - 8.08 MB)
Presents an overview of PDMPs for prescribers.
This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 (PDF - 609 KB) and Volume 2 (PDF - 1.3 MB) of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.
Presents an overview of PDMPs for prescribers.
Helps ensure patients who are beginning long-term therapy with opioid analgesics understand the side effects, risks, conditions, and purpose of their treatment. Facilitates clear communication between patients and healthcare providers about long-term opioid therapy, defines treatment expectations, and resolves any patient questions or concerns.
Includes two sample patient agreement forms that can be used with patients who are beginning long-term treatment with opioid analgesics or other controlled substances. Helps ensure patients understand their role and responsibilities regarding their treatment and those of the healthcare providers, as well as the conditions under which their treatment may be terminated.
These are slides from a 2019 presentation on the results of a low barrier buprenorphine pilot program conducted by the San Francisco Department of Public Health.
An informational page on the Bloomberg American Health Initiative website which details facts and resources from their Fentanyl Overdose Reduction Checking Analysis Study (FORECAST).
A fact sheet which includes information about fentanyl for both people who use drugs and Healthcare providers.
Highlights the different types of opioids and medication-assisted treatment.